Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Multiple Myeloma 166Precursor Cell Lymphoblastic Leukemia-Lymphoma 47Lymphoma 23Neoplasms, Plasma Cell 21Leukemia 21Recurrence 20Burkitt Lymphoma 18Lymphoma, Non-Hodgkin 15Neoplasms 14Lymphoma, Mantle-Cell 14Immunoglobulin Light-chain Amyloidosis 14Nausea 13Lymphoma, Large B-Cell, Diffuse 13Vomiting 12Breast Neoplasms 12Hodgkin Disease 11Waldenstrom Macroglobulinemia 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Follicular 9Amyloidosis 9Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myeloid, Acute 8Smoldering Multiple Myeloma 7Neoplasm Metastasis 7Leukemia, Biphenotypic, Acute 6Hematologic Neoplasms 6Blast Crisis 6Prostatic Neoplasms 5Lymphoma, T-Cell, Cutaneous 5Lymphoma, B-Cell 5

Interventions

Cisplatin 28Pemetrexed 24pembrolizumab 12Nivolumab 10Carboplatin 9atezolizumab 7Gemcitabine 7Cyclophosphamide 7durvalumab 6Drug Therapy 6sodium thiosulfate 5Radiotherapy, Intensity-Modulated 5tremelimumab 4aldesleukin 4Radiotherapy 4Interleukin-2 4sargramostim 3Vinorelbine 3Platinum 3Photochemotherapy 3Ipilimumab 3Doxorubicin 3Dihematoporphyrin Ether 3Chemotherapy, Adjuvant 3Cerebral Decortication 3vatalanib 2regorafenib 2niraparib 2lenvatinib 2cemiplimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Mesothelioma, Malignant × Calcium Dobesilate × Clear all
NCT00402766 2015-11-18

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

M.D. Anderson Cancer Center

Phase 1 Completed
19 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡